|
SLC7A6OS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.546600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.049800E-01 |
| Normal-vs-Stage2 |
9.734600E-01 |
| Normal-vs-Stage3 |
1.360220E-02 |
| Normal-vs-Stage4 |
1.670100E-02 |
| Stage1-vs-Stage2 |
6.018200E-01 |
| Stage1-vs-Stage3 |
8.752400E-04 |
| Stage1-vs-Stage4 |
9.449600E-04 |
| Stage2-vs-Stage3 |
7.285700E-02 |
| Stage2-vs-Stage4 |
6.624100E-02 |
| Stage3-vs-Stage4 |
9.456800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.360000E-01 |
| Normal-vs-AfricanAmerican |
9.744200E-01 |
| Normal-vs-Asian |
1.832400E-01 |
| Caucasian-vs-AfricanAmerican |
4.909400E-01 |
| Caucasian-vs-Asian |
3.735500E-02 |
| AfricanAmerican-vs-Asian |
1.481430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.341800E-01 |
| Normal-vs-Female |
8.195200E-01 |
| Male-vs-Female |
3.388200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.987200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.788200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.469800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.562600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.167600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.671000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.056400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.304400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.868000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.589400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.417500E-03 |
| Normal-vs-Grade 2 |
7.529800E-01 |
| Normal-vs-Grade 3 |
3.267800E-01 |
| Normal-vs-Grade 4 |
1.002060E-02 |
| Grade 1-vs-Grade 2 |
7.571900E-04 |
| Grade 1-vs-Grade 3 |
1.678900E-03 |
| Grade 1-vs-Grade 4 |
2.016800E-04 |
| Grade 2-vs-Grade 3 |
4.430000E-01 |
| Grade 2-vs-Grade 4 |
1.280360E-02 |
| Grade 3-vs-Grade 4 |
5.518200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.168400E-01 |
| Normal-vs-ccB subtype |
7.742400E-02 |
| ccA subtype-vs-ccB subtype |
2.424200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.701600E-01 |
| Normal-vs-N1 |
3.442400E-01 |
| N0-vs-N1 |
4.060000E-01 |
|
|
